-+ 0.00%
-+ 0.00%
-+ 0.00%

Alnylam Pharmaceuticals Price Target Cut to $410.00/Share From $470.00 by Freedom Capital Markets

Dow Jones·02/17/2026 14:56:00

Please log in to view news